🔎 Trials Near Me

Acasă › Boala Parkinson › Texas

Studii clinice pentru Boala Parkinson în Texas

26 studii pentru Boala Parkinson caută participanți în Texas.

Orașe în Texas

Text oficial al studiului (în engleză)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  • Neurology Consultants of Dallas PA, Dallas
  • Baylor College of Medicine, Houston
  • The University of Texas Health Science Center at Houston, Houston
  • și încă 1
În curs de recrutareFaza 2
Vârste de la 40 la 80 · Toate sexele · Actualizat 2 oct. 2026 · NCT06680830

Motor Network Physiology

  • UT Southwestern Medical Center, Dallas
În curs de recrutare
Vârste de la 18 la 89 · Toate sexele · Actualizat 1 oct. 2026 · NCT04957095

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  • Site-043, Round Rock
În curs de recrutareFaza 2/3
Vârste de la 40 la 80 · Toate sexele · Actualizat 28 sept. 2026 · NCT06976268

A Study of Buntanetap in Participants With PD

  • Central Texas Neurology, Round Rock
În curs de recrutareFaza 2/3
Vârste de la 40 la 85 · Toate sexele · Actualizat 21 sept. 2026 · NCT07284784

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

  • Houston Methodist Research Institute, Houston
  • University of Texas Health Medical Arts and Research Center, San Antonio
  • Texas Institute for Neurological Disorders, Sherman
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT02071134

Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation

  • Callier Clinical Center, The University of Texas at Dallas, Richardson
În curs de recrutare
Vârste de la 50 la 90 · Toate sexele · Actualizat 16 sept. 2026 · NCT07534397

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #049, Cypress
  • Vima Site #063, Dallas
  • Vima Site #058, Round Rock
În curs de recrutareFaza 2
Vârste de la 18 la 65 · Toate sexele · Actualizat 11 sept. 2026 · NCT07804615

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

  • Horizon Clinical Research: Gill Neuroscience - Houston (Site #232), Cypress
  • Central Texas Neurology Consultants (Site #203), Round Rock
În curs de recrutareFaza 2
Vârste de la 30 la 80 · Toate sexele · Actualizat 10 sept. 2026 · NCT07432958

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations

  • Central Texas Neurology Consultants (CTNC), Round Rock
În curs de recrutareFaza 2
Vârste de la 40 la 85 · Toate sexele · Actualizat 8 sept. 2026 · NCT07514858

Parkinson's Foundation PD GENEration Genetic Registry

  • Baylor College of Medicine, Houston
  • The University of Texas Health Science Center at Houston, Houston
  • University of Texas at San Antonio, San Antonio
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 8 sept. 2026 · NCT04994015

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

  • Baylor College of Medicine, Houston
  • University of Texas Health Science Center at Houston, Houston
În curs de recrutareStudiu observațional
Vârste de la 45 la 75 · Toate sexele · Actualizat 4 sept. 2026 · NCT07330258

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  • Texas Neurology PA, Dallas
  • Central Texas Neurology Consultants, Round Rock
În curs de recrutareFaza 3
Vârste de la 50 la 85 · Toate sexele · Actualizat 3 sept. 2026 · NCT07174310

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

  • Texas Movement Disorder Specialists /ID# 278565, Georgetown
În curs de recrutareStudiu observațional
Vârste de la 18 la 80 · Toate sexele · Actualizat 1 sept. 2026 · NCT07227896

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  • UTHealth Houston Neurosciences - Texas Medical Center, Houston
În curs de recrutareFaza 3
Vârste de la 45 la 75 · Toate sexele · Actualizat 4 aug. 2026 · NCT06944522

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • Baylor College of Medicine, Houston
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de 30 ani și peste · Toate sexele · Actualizat 27 iul. 2026 · NCT04477785

18F-mFBG Cardiac Uptake With Lewy Body Dementia

  • Houston Methodist Neurological Institute, Houston
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 iul. 2026 · NCT07176286

Sensing in Sleep Deep Brain Stimulation

  • The University of Texas Health Science Center at San Antonio - Brain Health Center, San Antonio
În curs de recrutare
Vârste de la 40 la 80 · Toate sexele · Actualizat 9 iun. 2026 · NCT07636720

Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

  • University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El Paso
  • Move Therapy Services, El Paso
În curs de recrutare
Vârste de 50 ani și peste · Toate sexele · Actualizat 8 mai 2026 · NCT07221266

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

  • PPD Development, LP, Austin
În curs de recrutareFaza 1Voluntari sănătoși bineveniți
Vârste de la 30 la 85 · Toate sexele · Actualizat 20 apr. 2026 · NCT06809400

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

  • University of Texas Health Science Center at San Antonio, San Antonio
În curs de recrutare
Vârste de la 40 la 85 · Toate sexele · Actualizat 31 mar. 2026 · NCT06508801

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

  • University of Texas Southwestern Medical Center, Dallas
În curs de recrutareStudiu observațional
Vârste de la 30 la 99 · Toate sexele · Actualizat 20 mar. 2026 · NCT05539196

Black and African Americans Connections to Parkinson's Disease (BLAAC PD)

  • University of Texas Health Science Center, Houston, Houston
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de 18 ani și peste · Toate sexele · Actualizat 27 feb. 2026 · NCT06719583

Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging

  • UT Southwestern Medical Center, Dallas
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Toate vârstele · Toate sexele · Actualizat 27 ian. 2026 · NCT03872102

Action Regulation Behavioral

  • University of Texas Southwestern Medical Center, Dallas
În curs de recrutareVoluntari sănătoși bineveniți
Vârste de la 18 la 80 · Toate sexele · Actualizat 12 dec. 2025 · NCT06489483

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  • Neurology Consultants of Dallas, PA, Dallas
  • Texas Movement Disorder Specialists, PLLC, Georgetown
  • Icahn School of Medicine at Mount Sinai, Houston
  • și încă 1
În curs de recrutareFaza 4
Vârste de 18 ani și peste · Toate sexele · Actualizat 24 aug. 2025 · NCT06765668

SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

  • University of Texas Southwestern Medical Center, Dallas
În curs de recrutare
Vârste de la 50 la 85 · Toate sexele · Actualizat 13 aug. 2025 · NCT05982730

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.